Safety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma

NCT04696731 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced/Metastatic Clear Cell Renal Cell Carcinoma

Interventions

GENETIC: ALLO-316
BIOLOGICAL: ALLO-647
DRUG: Fludarabine
DRUG: Cyclophosphamide

Sponsor

Allogene Therapeutics